当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Muhammad Usman Shams
Precision medicine is an emerging field in medicine for disease prevention and treatment that takes into account biological characteristics of an individual patient to allow delivery of more individualized medical care. In the case of cancer, such biological characteristics are based largely on analysis of tumor tissue. With the advent of modern techniques like immunohistochemistry & gene sequencing and the enhanced understanding of the tumor immune microenvironment, the modern pathology labs are able to derive more and more biologically useful information from biospecimens. This information has not only allowed sub-classification of cancers for better therapeutic and prognostic knowledge, but also has provided unprecedented possibilities to study the biology of pre-malignancy. Journey of modern pathology towards precision medicine in cancer is expected to provide unique opportunities for the dissemination and implementation of public health interventions.